With the known varied efficiency in reporting congenital malformations the observed rates of reported malformations form a collection of data which must be interpreted with caution especially for epidemiological study of geographical, social or other causes. The body of data does, however, form a depot of material which can be used for retrospective enquiries and also gives some minimal evidence about the incidence ofmalformations which do not necessarily cause stillbirth or death. REFERENCES Hill G B, Spicer C C & Weatherall J A C (1968) Brit. med. Bull. 24, 215 Weatherall J A C (1969) Med. Offr. 121, 65 Mr F M Sullivan (Department ofPharmacology, Guy's Hospital Medical School, London SEI)
Mechanisms ofAction of Teratogenic Drugs
Since the discovery of the teratogenic action of thalidomide in man, practically all new drugs intended either for human or animal use are tested for teratogenic activity in animals. The relevance of such animal tests for man is always difficult to assess but a knowledge of the mode of action of the drug in causing fcetal abnormalities can be exceedingly useful. Furthermore, investigations into the modes of action of teratogenic drugs can reveal much which is of interest in considering the etiology of spontaneous congenital malformations.
Possible Sites ofAction ofTeratogens
A direct toxic action on the fcetus such as occurred with thalidomide is by no means the only or even the most important action of teratogens. Drugs may produce malformations in the ftetus by an action on any of the following: the fetus, ftetoplacental unit, mother or father. The types of action at these sites can be classified as follows: In a brief review it is not possible to discuss drugs which act at all these sites though such examples do exist. Drugs may act at more than one site; in fact, this is probably the rule rather than the exception since drugs which affect ;the metabolism of the mother will probably also affect the fcetus if they cross the placental barrier.
A few examples to illustrate the action of drugs at the varlous sites will be given.
Drugs or Metabolites Directly Toxic to the Fetus
Drugs which act directly on the foetus may produce a characteristic type of deformity. It is probable that thalidomide acted directly on embryos to produce the phocomelia or amelia so typical of this drug. Whether it was the thalidomide itself or its hydrolysis products or metabolites which were teratogenic is still not known (Williams 1968 ).
Many anti-tumour drugs such as aminopterin, methotrexate, busulphan, &c., have been implicated in congenital malformations in humans. It is generally assumed that the cytotoxic and immunosuppressive activity of these drugs accounts for their teratogenic activity. This may not be so, however, since Tuchmann-Duplessis & Mercier- Parot (1965) have shown that the teratogenic activity of azathioprine (Imuran) in rabbits is not affected by simultaneous administration of cysteine or glutathione which abolishes the antitumour activity ofthe drug.
Another group of drugs directly toxic to the fcetus is the antibiotics, and there is clear evidence that the tetracyclines can become incorporated into and produce defects in the teeth of children whose mothers are treated during pregnancy (Douglas 1963 , Weyman 1965 .
Drugs Indirectly Toxic to the Fetus Drugs may cause malformations by interfering with feetal metabolism, such as folic acid antagonists like aminopterin or methotrexate which are known to be teratogenic in man (Thiersch 1952 , Milunsky et al. 1968 ). Whether drugs are regarded as 'directly' or 'indirectly' toxic to the foetus may often merely be a reflection of our own ignorance regarding their mode of action. Thus the antiepileptic drugs which are thought to be teratogenic in man (Meadow 1970 ) may also act by inhibiting folic acid.
Pharmacodynamic Effects on the Faetus Substances which are vasoactive may pass through the placenta and produce deformities of the offspring. It has been shown that catecholamines and vasopressin are teratogenic in animals (Sullivan 1965 ). Part of their action is probably to produce vasospasm in the limbs of the foetus with a resulting loss from gangrenous necrosis (Davies & Robson 1970) . Other examples of such pharmacological effects could include paralytic ileus and death of the newborn following hexamethonium administration to the mother (Morris 1953) , or fatal withdrawal syndromes in the newborn of narcotic addicts (Schneck 1958) .
Endocrine Balance ofthe Fwtus
There are numerous reports of congenital abnormalities, especially virilization of female foetuses following treatment of the mother with cestrogens, androgens or progestogens (Lionel 1969) . Similarly antithyroid, hypoglycvmic drugs, &c., may result in impaired survival of the newborn;
Drugs Affecting the Fetoplacental Unit Amniotic fluid: Cortisone is quite a powerful teratogen in some species (mouse and rabbit) but not in others (rat). It commonly produces cleft palate in susceptible animals but no one has been able to correlate any particular action of cortisone with the development of cleft palate. However, an interesting mechanistic interpretation of cortisone-induced cleft palate has been proposed by Harris (1964) . He showed that cortisone, in susceptible animals, causes a reduction in amniotic fluid volume which results in flexion of the head so that the tongue prevents palatal closure. Jost (1969) has stated that puncture of amniotic fluid can result in cleft palate.
Placental BloodFlow and Transfer ofNutrients
Substances such as serotonin (5-hydroxytryptamine) can produce all types of congenital malformation of the central nervous system, skeleton, body wall, &c., by reducing placental blood flow on the maternal side and so depriving the foetus of adequate nutrition (Davies et al. 1969) . Trypan blue probably also acts as a teratogen by reducing foetal nutrition without even entering the foetus (Beck et al. 1967 ).
Drugs Affecting the Mother
Substances which affect the nutritional or biochemical status of the mother, e.g. to produce hyperglycaemia or hypercholesterolkmia, may cause developmental anomalies in the offspring (Tuchmann-Duplessis 1969) . Psychotropic drugs such as the phenothiazines and amine oxidase inhibitors may produce marked changes in the endocrine balance of the mother or have a direct antiprogesterone activity (Jaitly et al. 1968) . The resulting hormone deficiency may then cause the development of congenital malformations which can be prevented by simultaneous administration of the appropriate hormone .
Drugs Affecting the Father The teratogenic effects of drugs when administered to the male have been remarkably little studied. There is evidence, however, that drugs, including thalidomide, can affect foetal development when given to the male (Lutwak-Mann 1965) .
Conclusion
The examples of drug-induced teratogenesis quoted illustrate some of the ways in which drugs can act to affect the foetus. It is striking that in many of the cases the drug does not even cross the placental barrier or enter the fetus. By a careful consideration of some of these actions at an early stage of drug toxicity testing it is to be hoped that a rational interpretation and extrapolation of animal studies may be made so that a further disaster such as that caused by thalidomide may be averted. Part of the fallout of such studies will undoubtedly be the shedding of more light on the etiology of spontaneous malformations.
